Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia
Abstract Introduction TV-46000 is a long-acting subcutaneous antipsychotic (LASCA) agent that combines risperidone and an innovative, copolymer-based drug delivery technology in a suspension suitable for subcutaneous administration from a prefilled syringe. The objective of the current analysis was...
Saved in:
| Main Authors: | Itay Perlstein, Avia Merenlender Wagner, Anna Elgart, Anthe S. Zandvliet, Farina Hellmann, YuWei Lin, Eline van Maanen, Nele Plock, Floris Fauchet, Rajendra Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-03-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-025-00723-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans
by: Lilach Steiner, et al.
Published: (2025-01-01) -
Flash Chromatography Application for Risperidone Purification
by: G. S. Trush, et al.
Published: (2015-08-01) -
Histological and Biochemical Changes in Ovaries of Adult Wistar Rats Following Exposure to Risperidone
by: Onyilo, P.O.*, Dirisu, E.I., Samuel, B.O.
Published: (2024-11-01) -
The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al. -
Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly
by: Jerson Laks, et al.
Published: (2001-12-01)